These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 963910)

  • 1. A new haemolytic assay for the second component of complement (C2) in human serum.
    Naish PF; Barratt J; Collins C
    Clin Exp Immunol; 1976 Sep; 25(3):487-9. PubMed ID: 963910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple one-step hemolytic assay for C2 with C2-deficient human serum.
    Ngan BY; Gelfand EW; Minta JO
    J Immunol; 1977 Mar; 118(3):736-41. PubMed ID: 321681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement.
    Knutzen Steuer KL; Sloan LB; Oglesby TJ; Farries TC; Nickells MW; Densen P; Harley JB; Atkinson JP
    J Immunol; 1989 Oct; 143(7):2256-61. PubMed ID: 2506280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing of hemolytic complement components in domestic animals.
    Barta O; Hubbert NL
    Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Coagulation studies in C4-deficient guinea pigs.
    Dodds WJ; Raymond SL; Moynihan AC; Pickering RJ; Amiraian K
    Thromb Diath Haemorrh; 1975 Nov; 34(2):602. PubMed ID: 1198523
    [No Abstract]   [Full Text] [Related]  

  • 6. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.
    Nakajima S; Baba AS; Tamura N
    Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between plasma and serum complement in patients with chronic liver disease.
    Inai S; Kitamura H; Fujita T; Kojima J; Nagaki K
    Clin Exp Immunol; 1976 Sep; 25(3):403-9. PubMed ID: 963909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a rapid kinetic assay for the function of the classical pathway of the complement system and for C2 and C4.
    Kolde HJ; Deubel R
    J Clin Lab Immunol; 1986 Dec; 21(4):201-7. PubMed ID: 3560196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement component analysis in angiodema. Diagnostic value.
    Brasher GW; Starr JC; Hall FF; Spiekerman AM
    Arch Dermatol; 1975 Sep; 111(9):1140-2. PubMed ID: 1167046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
    Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
    J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hereditary non-allergic angioneurotic edema and the complement system (author's transl)].
    Exss R; Britz I
    Klin Padiatr; 1976 Mar; 188(2):194-200. PubMed ID: 944358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement determinations in the synovial fluid and serum of a patient with Erythema nodosum leprosum.
    Louie JS; Glovsky M
    Int J Lepr Other Mycobact Dis; 1975; 43(3):252-5. PubMed ID: 1240873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1-bypass complement-activation pathway in patients with chronic urticaria and angio-oedema.
    Ballow M; Ward GW; Gershwin ME; Day NK
    Lancet; 1975 Aug; 2(7928):248-50. PubMed ID: 49798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modulation of the alternative pathway of complement in C2-deficient human serum by changes in concentration of the component and control proteins.
    Nydegger UE; Fearon DT; Austen KF
    J Immunol; 1978 Apr; 120(4):1404-8. PubMed ID: 565382
    [No Abstract]   [Full Text] [Related]  

  • 15. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)].
    Roncato M; Vial MC; Maillet F; Peltier A
    Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The second component of complement (C2) as an index of hereditary angioneurotic edema.
    Sobel AT; Moisy M; Belghiti D; Gabay Y; Lagrue G
    J Clin Lab Immunol; 1978 Nov; 1(3):179-81. PubMed ID: 756467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complement in rheumatoid articular inflammation].
    Boloşiu HD; Duţu A; Duţu D; Duma V; Gligore V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(6):469-74. PubMed ID: 3842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.